CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 99 enrolled
Drug / intervention
ergocalciferoldrug
Likely dose
ergocalciferol 50,000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00742235
NCT00742235N/ACompleted

hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects

Massachusetts General Hospital·interventional·Posted Aug 27, 2008·Updated Apr 14, 2016

In Brief

A clinical study evaluating ergocalciferol for Healthy Subjects and Vitamin D Deficiency. Completed, enrolled 99 participants across 1 site.

Detailed Summary

Vitamin D deficiency (low levels of vitamin D in the blood) is a common problem. A recently discovered protein, called hCAP18, likely plays an important role in the immune system and may depend on adequate levels of vitamin D. It is not known what levels of vitamin D are needed to allow the body to make this protein. Nor is it known if giving vitamin D to people who are found to be deficient will help boost levels of hCAP18. This study aims to clarify the relationship between vitamin D levels and hCAP18.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 27, 2008
Enrollment StartJul 1, 2007
Primary CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 17.8 years ago

Interventions

ergocalciferoldrug

Ergocalciferol 50,000 IU given every other day for 5 total doses